Recent Advancements of Anti-cancer Nanomedicine in Breast Cancer

Jiachen Li

2022

Abstract

Nanomedicine is a novel type of cancer treatment that has been applied to clinical practice for its identified safety and potency against cancer cells and safety. Conventional cancer treatments such as surgery, radiation, and chemotherapy work generally well but inevitably bring severe adverse reactions and sometimes unsatisfying results. Breast cancer is one of the most major cancer with high incidence rate and mortality rate, characterized by high risks and a great reduction in of life quality of life with high incidence rate and mortality rate. In the past three decades, nanotechnology emerged to giving rise to novel forms offer anti-cancer drug delivery systems and offering greater therapeutic therapeutical advantages than traditional cancer treatments can do. With the incorporation of nanocarriers, higher drug loading efficiency, targeted delivery, enhanced bioavailability, and stronger cytotoxicity, and less side effects can be achieved. This paper shows the recent developments of nanocarrier-incorporated anti-cancer drugs with specific to breast cancer. Ways of newly synthesized drug loaded nanoparticles alleviating side effects from conventional treatments and improving therapeutic effects are stressed in this paper.

Download


Paper Citation


in Harvard Style

Li J. (2022). Recent Advancements of Anti-cancer Nanomedicine in Breast Cancer. In Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB, ISBN 978-989-758-595-1, pages 152-159. DOI: 10.5220/0011192400003443


in Bibtex Style

@conference{icbeb22,
author={Jiachen Li},
title={Recent Advancements of Anti-cancer Nanomedicine in Breast Cancer},
booktitle={Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB,},
year={2022},
pages={152-159},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0011192400003443},
isbn={978-989-758-595-1},
}


in EndNote Style

TY - CONF

JO - Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB,
TI - Recent Advancements of Anti-cancer Nanomedicine in Breast Cancer
SN - 978-989-758-595-1
AU - Li J.
PY - 2022
SP - 152
EP - 159
DO - 10.5220/0011192400003443